Related Experiment Video
Updated: Mar 30, 2026

Isolation of Soil Microorganisms Using iChip Technology
Published on: January 10, 2025
Microbial chassis selection for niche-specific engineered live biotherapeutics.
Dongmin Byun1, Li Ting Lee1, Chenxin Zhang1
1NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore; Synthetic Biology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; National Centre for Engineering Biology (NCEB), Singapore, Singapore; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Selecting the right microbial chassis is key for engineered live biotherapeutic products (eLBPs). This review covers chassis for various body sites, aiding therapeutic development.
Area of Science:
- Microbiology
- Biotechnology
- Therapeutics
Background:
- The human microbiota is crucial for health and disease modulation.
- Engineered live biotherapeutic products (eLBPs) use modified microbes for therapeutic functions.
- Selecting an appropriate microbial chassis is vital for eLBP efficacy and safety.
Purpose of the Study:
- To review microbial chassis used in eLBPs for specific body niches.
- To highlight chassis characteristics suitable for gut, skin, vagina, and tumor microenvironments.
- To discuss strategies for enhancing eLBP colonization and identify future candidates.
Main Methods:
- Literature review of microbial chassis in eLBP development.
- Analysis of chassis suitability for different host niches (gut, skin, vagina, tumor).
- Examination of strategies for improving eLBP colonization and efficacy.
Main Results:
- Various microbial chassis are employed for specific niches, with characteristics tailored to each.
- Chassis selection impacts eLBP survival, colonization, and therapeutic function.
- Strategies exist to improve eLBP colonization and performance in target niches.
Conclusions:
- Rational chassis selection is essential for durable and effective eLBPs.
- Understanding niche-specific requirements guides the development of advanced eLBPs.
- Emerging microbial candidates show promise for future biotherapeutic applications.
More Related Videos
10:51Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device
Published on: August 30, 2016
06:24Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
Related Concept Videos
iChip
Upstream Processing
Microorganisms in Medicine and Therapeutics
Bioreactor Controls-III
Bioreactor Design and Operational System
Scale-Up Processes